3 days Kura Crashes 37% After $1.53 Billion Deal Slams The Door On A TakeoverInvestor's Business Daily
Kura Oncology slammed the door on its takeover narrative Thursday, inking a deal for its leukemia drug. Kura stock crashed.
The post Kura Crashes 37% After $1.53 Billion Deal Slams The Door On A Takeover appeared first on Investor's Business Daily.